Cardia Bioplastics Limited (ASX:CNN) (OTCMKTS:CDRBY) is pleased to
announce that Australian Stellar Films and Cardia Bioplastics have
partnered to produce environmentally friendly, high quality and cost
competitive Biohybrid(TM) films tailored for the global personal care
and hygiene products industry.
HOUSTON, TX--(Marketwired - November 24, 2014) - Stellus Capital Investment Corporation (NYSE: SCM) ("the Company") entered into a First Amendment (the "Amendment") to its Senior Secured Revolving Credit Agreement (the "Credit Facility"), between the Company, SunTrust Bank, as a lender and the administrative agent, and the lenders named therein.
Stellus Capital Investment Corporation (the “Company”) (NYSE: SCM)
announced today that on October 14, 2014, its Board of Directors
declared a regular monthly dividend for each of October, November and
December for an aggregate of $0.34 per share.
HOUSTON, TX--(Marketwired - November 06, 2014) - Stellus Capital Investment Corporation (NYSE: SCM) ("Stellus" or "the Company") today announced financial results for its third fiscal quarter ended September 30, 2014.
Sign-up for Stemline Therapeutics Announces Multiple Preclinical Presentations Highlighting Its Pipeline of IL-3R-Directed Therapeutics at the American Society of Hematology (ASH) Annual Meeting investment picks
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.